SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹0.11 Cr | ₹0.34 Cr | ₹0.25 Cr | ₹0.46 Cr | ₹0.43 Cr |
What is the latest Total Non-Current Liabilities ratio of SAMRAT PHARMACHEM ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹0.11 Cr |
| Mar2024 | ₹0.34 Cr |
| Mar2023 | ₹0.25 Cr |
| Mar2022 | ₹0.46 Cr |
| Mar2021 | ₹0.43 Cr |
How is Total Non-Current Liabilities of SAMRAT PHARMACHEM Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.11 Cr | -66.96 | |
| Mar2024 | ₹0.34 Cr | 32.28 | |
| Mar2023 | ₹0.25 Cr | -44.90 | |
| Mar2022 | ₹0.46 Cr | 6.47 | |
| Mar2021 | ₹0.43 Cr | - | |
Compare Total Non-Current Liabilities of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹62.6 Cr | -6.5% | -4.7% | -40.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | -6.5% |
-4.7% |
-40.6% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses